SIGA Technologies
SIGA
#8719
Rank
ยฃ0.16 B
Marketcap
ยฃ2.34
Share price
-1.27%
Change (1 day)
-55.32%
Change (1 year)

Revenue for SIGA Technologies (SIGA)

Revenue in 2026 (TTM): ยฃ68.55 Million

According to SIGA Technologies's latest financial reports the company's current revenue (TTM ) is ยฃ70.41 Million. In 2025 the company made a revenue of ยฃ70.22 Million a decrease over the revenue in the year 2024 that were of ยฃ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SIGA Technologies from 1997 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ68.55 M-2.37%
2025 ยฃ70.22 M-36.47%
2024 ยฃ0.11 B0.65%
2023 ยฃ0.10 B19.94%
2022 ยฃ91.56 M-7.54%
2021 ยฃ99.02 M8.02%
2020 ยฃ91.67 M349.53%
2019 ยฃ20.39 M-94.57%
2018 ยฃ0.37 B4039.94%
2017 ยฃ9.07 M-25.26%
2016 ยฃ12.14 M120.16%
2015 ยฃ5.51 M173.57%
2014 ยฃ2.01 M-39.73%
2013 ยฃ3.34 M-39.71%
2012 ยฃ5.55 M-32.21%
2011 ยฃ8.18 M-34.23%
2010 ยฃ12.44 M45.84%
2009 ยฃ8.53 M55.1%
2008 ยฃ5.5 M63.21%
2007 ยฃ3.37 M-8.99%
2006 ยฃ3.7 M-24.62%
2005 ยฃ4.91 M413.11%
2004 ยฃ0.95 M134.19%
2003 ยฃ0.4 M
2001 ยฃ0.79 M147.05%
2000 ยฃ0.32 M23.07%
1999 ยฃ0.26 M-12.53%
1998 ยฃ0.3 M-45.12%
1997 ยฃ0.54 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ1.63 B 2,229.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.44 B 535.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.65 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.66 B 844.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.48 B 588.66%๐Ÿ‡บ๐Ÿ‡ธ USA